These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 34370466)

  • 21. Differential expression of the amyloid SAA 3 gene in liver and peritoneal macrophages of mice undergoing dissimilar inflammatory episodes.
    Rokita H; Shirahama T; Cohen AS; Meek RL; Benditt EP; Sipe JD
    J Immunol; 1987 Dec; 139(11):3849-53. PubMed ID: 3680951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AA amyloid fibrils from diseased tissue are structurally different from in vitro formed SAA fibrils.
    Bansal A; Schmidt M; Rennegarbe M; Haupt C; Liberta F; Stecher S; Puscalau-Girtu I; Biedermann A; Fändrich M
    Nat Commun; 2021 Feb; 12(1):1013. PubMed ID: 33579941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum amyloid A protein (SAA) subtypes in acute and chronic inflammatory conditions.
    Maury CP; Ehnholm C; Lukka M
    Ann Rheum Dis; 1985 Oct; 44(10):711-5. PubMed ID: 3931569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary Intake of Rosmarinic Acid Increases Serum Inhibitory Activity in Amyloid A Aggregation and Suppresses Deposition in the Organs of Mice.
    Lin X; Watanabe K; Kuragano M; Kurotaki Y; Nakanishi U; Tokuraku K
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenetic mechanisms of amyloid A amyloidosis.
    Simons JP; Al-Shawi R; Ellmerich S; Speck I; Aslam S; Hutchinson WL; Mangione PP; Disterer P; Gilbertson JA; Hunt T; Millar DJ; Minogue S; Bodin K; Pepys MB; Hawkins PN
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16115-20. PubMed ID: 23959890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis.
    Jayaraman S; Gantz DL; Haupt C; Gursky O
    Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6507-E6515. PubMed ID: 28743750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational flexibility of the serum amyloid precursor SAA.
    Sipe JD; McAdam KP; Torain BF; Glenner GG
    Br J Exp Pathol; 1976 Oct; 57(5):582-92. PubMed ID: 999792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent insights into the pathogenesis of type AA amyloidosis.
    van der Hilst JC
    ScientificWorldJournal; 2011 Mar; 11():641-50. PubMed ID: 21403980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural history and outcome in systemic AA amyloidosis.
    Lachmann HJ; Goodman HJ; Gilbertson JA; Gallimore JR; Sabin CA; Gillmore JD; Hawkins PN
    N Engl J Med; 2007 Jun; 356(23):2361-71. PubMed ID: 17554117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA sequence evidence for polymorphic forms of human serum amyloid A (SAA).
    Kluve-Beckerman B; Long GL; Benson MD
    Biochem Genet; 1986 Dec; 24(11-12):795-803. PubMed ID: 3800865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of the N-Terminal Helix and Its Role in Amyloid Formation of Serum Amyloid A.
    Wang W; Xi W; Hansmann UHE
    ACS Omega; 2018 Nov; 3(11):16184-16190. PubMed ID: 30533585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A.
    Aguilera JJ; Zhang F; Beaudet JM; Linhardt RJ; Colón W
    Biochimie; 2014 Sep; 104():70-80. PubMed ID: 24878279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum amyloid protein SAA, C-reactive protein and lysozyme in leprosy.
    Scheinberg MA; Masuda A; Benson MD; Mendes NF
    Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2):133-7. PubMed ID: 572349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human lysozyme inhibits the fibrillation of serum amyloid a protein from systemic AA amyloidosis.
    Moderer T; Puşcalău-Gîrţu I; Haupt C; Baur J; Rodríguez-Alfonso A; Wiese S; Schmidt CQ; Malešević M; Forssmann WG; Ständker L; Fändrich M
    Amyloid; 2023 Dec; 30(4):424-433. PubMed ID: 37431668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve.
    Gursky O
    Curr Atheroscler Rep; 2020 Sep; 22(11):69. PubMed ID: 32968930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical value of serum amyloid A and C-reactive protein measurements in secondary amyloidosis.
    Maury CP; Wegelius O
    Int J Tissue React; 1985; 7(5):405-7. PubMed ID: 4055265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis.
    Li H; Xiang X; Ren H; Xu L; Zhao L; Chen X; Long H; Wang Q; Wu Q
    J Infect; 2020 Jun; 80(6):646-655. PubMed ID: 32277967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation.
    Röcken C; Menard R; Bühling F; Vöckler S; Raynes J; Stix B; Krüger S; Roessner A; Kähne T
    Ann Rheum Dis; 2005 Jun; 64(6):808-15. PubMed ID: 15897303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transmission of systemic AA amyloidosis in animals.
    Murakami T; Ishiguro N; Higuchi K
    Vet Pathol; 2014 Mar; 51(2):363-71. PubMed ID: 24280941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural requirements of glycosaminoglycans for facilitating amyloid fibril formation of human serum amyloid A.
    Takase H; Tanaka M; Yamamoto A; Watanabe S; Takahashi S; Nadanaka S; Kitagawa H; Yamada T; Mukai T
    Amyloid; 2016 Jun; 23(2):67-75. PubMed ID: 27097047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.